Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1989 | 06-1989 | 03-1989 | 12-1988 | 09-1988 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,032 | 1,053 | 1,621 | 1,211 | 2,419 |
| Marketable Securities | 0 | 0 | 313 | 312 | 383 |
| Receivables | 0 | 0 | 0 | 0 | 12 |
| Other current assets | 113 | 15 | 777 | 36 | 275 |
| TOTAL | $1,145 | $1,068 | $2,711 | $1,560 | $3,089 |
| Non-Current Assets | |||||
| PPE Net | 285 | 283 | 282 | 283 | 348 |
| Other Non-Current Assets | 324 | 325 | 12 | 12 | 12 |
| TOTAL | $609 | $608 | $294 | $295 | $360 |
| Total Assets | $1,543 | $1,476 | $2,815 | $1,674 | $3,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 543 | 763 | 1,048 | 1,254 | 463 |
| Accrued Expenses | 42 | 70 | 30 | 109 | 12 |
| Other current liabilities | 5 | 5 | 5 | 5 | 7 |
| TOTAL | $590 | $838 | $1,083 | $1,368 | $482 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 490 | 480 | 466 | 26 | 409 |
| TOTAL | $490 | $480 | $466 | $457 | $409 |
| Total Liabilities | $1,080 | $1,318 | $1,549 | $1,825 | $891 |
| Shareholders' Equity | |||||
| Common Shares | 126 | 120 | 117 | 116 | 115 |
| Retained earnings | -34,534 | -33,233 | -31,049 | -29,437 | -26,403 |
| Other shareholders' equity | -48 | -68 | -88 | -107 | -223 |
| TOTAL | $463 | $158 | $1,266 | $-151 | $2,299 |
| Total Liabilities And Equity | $1,543 | $1,476 | $2,815 | $1,674 | $3,190 |